Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Localized beta radiation targets tumor cells by delivering cytotoxic energy through high-energy electrons emitted from radioisotopes. Its effectiveness relies on both direct targeting and collateral destruction ("cross-fire") within solid tumors. While this approach offers significant advantages over non-selective external beam radiotherapy—especially regarding selectivity—it still carries risks such as myelosuppression and potential induction of pro-metastatic cellular changes if not carefully managed.
Delivery of localized beta radiation to tumor cells, inducing DNA damage and cell death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cells via Localized Beta Radiation.